By Chris Wack
Acorda Therapeutics shares were up 75% to 87 cents on Monday after the company said it entered into distribution and supply agreements with Hangzhou Chance Pharmaceuticals to provide its Parkinson’s treatment Inbrija in China.
The stock is down 11% in the past 12 months.
Under…
Read the full article here
